2-carboxyarabinitol 1-phosphate has been researched along with 1-benzylpiperazine in 1 studies
| Studies (2-carboxyarabinitol 1-phosphate) | Trials (2-carboxyarabinitol 1-phosphate) | Recent Studies (post-2010) (2-carboxyarabinitol 1-phosphate) | Studies (1-benzylpiperazine) | Trials (1-benzylpiperazine) | Recent Studies (post-2010) (1-benzylpiperazine) |
|---|---|---|---|---|---|
| 17 | 0 | 13 | 92 | 7 | 37 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GW; Cho, MH; Churchwell, MI; Doerge, DR; Helferich, WG; Hergenrother, PJ; Hoagland, MS; Hwang, SK; Jin, H; Kwon, JT; Pearson, JM; Putt, KS; Sandhorst, JS | 1 |
1 other study(ies) available for 2-carboxyarabinitol 1-phosphate and 1-benzylpiperazine
| Article | Year |
|---|---|
Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Hydrazones; In Vitro Techniques; Mice; Mice, Nude; Molecular Structure; Piperazines; Signal Transduction; Structure-Activity Relationship; Time Factors; Xenograft Model Antitumor Assays | 2006 |